[Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
作者信息
Vecchietti G, Gerzeli G, Zanoio L, Novelli G G, Barni S
出版信息
Minerva Ginecol. 1979 Jul-Aug;31(7-8):597-603.
PMID:481819
Abstract
摘要
相似文献
1
[Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
Minerva Ginecol. 1979 Jul-Aug;31(7-8):597-603.
2
[MAP in the therapy of adenocarcionoma of the endometrium. Immediate clinical results and general endocrine effects].
Minerva Ginecol. 1975 Sep;27(9):744-53.
3
[Medroxyprogesterone and endometrial adenocarcinoma].
Bull Fed Soc Gynecol Obstet Lang Fr. 1970 Jan-Mar;22(1):93-7.
4
[Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
Minerva Ginecol. 1981 Oct;33(10):917-36.
5
[Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
Minerva Ginecol. 1981 Apr;33(4):293-306.
6
[MAP in the treatment of adenocarcinoma of the endometrium].
Minerva Ginecol. 1979 Apr;31(4):251-5.
7
[Action of MAP in adenocarcinoma of the endometrium. Clinical results and ultrastructural and histochemical study].
Minerva Ginecol. 1981 Oct;33(10):937-54.
8
Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Obstet Gynecol. 1977 Oct;50(4):415-7.
9
Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
Surg Forum. 1969;20:411-3.
10
[Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jul;37(7):1161-8.
Zotero 插件